We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+17.09%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.09B
AUM Growth
+$52.7M
Cap. Flow
-$42.7M
Cap. Flow %
-3.91%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CHPT icon
ChargePoint
CHPT
+$24.2M
2
TVRD
Tvardi Therapeutics
TVRD
+$18.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 76.77%
2 Technology 11.81%
3 Healthcare 9.8%
4 Communication Services 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHPT icon
1
ChargePoint
CHPT
$133M
$839M 76.77%
1,207,117
-45,691
-4% -$24.2M
ONTF
2
DELISTED
ON24
ONTF
$129M 11.81%
3,637,894
NGM
3
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$74.3M 6.8%
3,766,666
TVRD
4
Tvardi Therapeutics
TVRD
$23.5M
$21.4M 1.96%
41,641
-29,166
-41% -$18.5M
LVO icon
5
LiveOne
LVO
$66M
$17.6M 1.61%
372,414
MRSN
6
DELISTED
Mersana Therapeutics
MRSN
$10.8M 0.99%
31,858
SENS icon
7
Senseonics Holdings Inc
SENS
$254M
$613K 0.06%
7,980

Similar funds

Rho Capital Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Rho Capital Partners held 7 positions worth $1.09B, up 5.1% from $1.04B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners withdrew a net $42.7M in Q2 2021, reducing 2 holdings. Its largest reduction was ChargePoint, cutting an estimated $24.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 77% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

  • Rho Capital Partners's biggest Q2 2021 reduction was ChargePoint, cutting an estimated $24.2M.
  • Rho Capital Partners's ten largest holdings make up 100% of its $1.09B portfolio in Q2 2021.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q2 2021.
  • Rho Capital Partners's portfolio value rose 5.1% quarter-over-quarter to $1.09B.

Based on Rho Capital Partners's 13F filing for Q2 2021, filed 12 Aug 2021.